{
    "sec_cik": "0000875045",
    "sec_company_name": "BIOGEN INC. (Filer)",
    "document_type": "EX991",
    "sec_form_header": "Form 8-K",
    "sec_period_of_report": "20190129",
    "sec_filing_date": "20190129",
    "sec_changed_date": "20190129",
    "sec_accepted_date": "20190129064212",
    "sec_index_url": "https://www.sec.gov//Archives/edgar/data/875045/000087504519000002/0000875045-19-000002-index.htm",
    "sec_url": "https://www.sec.gov//Archives/edgar/data/875045/000087504519000002/0000875045-19-000002.txt",
    "metadata_file_name": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0008\003\BIIB_0000875045_EX991_20190129_EX-99_metadata.json",
    "original_file_name": "",
    "original_file_size": "726792 chars",
    "document_group": "EX-99",
    "section_name": "EX-99",
    "section_n_characters": 39604,
    "endpoints": [
        "Exhibit   ",
        "(1) On February 1, 2017, we completed the spin-off of our hemophilia business. Our consolidated results of operations reflect the financial results of our hemophilia business through January 31, 2017."
    ],
    "extraction_method": "html",
    "warnings": [],
    "company_description": "BIIB",
    "output_file": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0008\003\BIIB_0000875045_EX991_20190129_EX-99_excerpt.txt",
    "time_elapsed": 0.2,
    "batch_number": 8,
    "batch_signature": "",
    "batch_start_time": "2023-04-16 22:35:47.811513",
    "batch_machine_id": "DESKTOP-BTCJU5K",
    "section_end_time": "2023-04-16 22:55:17.128723"
}